Edition:
United Kingdom

Beyondspring Says Initiates Global Phase 2/3 Trial With Plinabulin In China


Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Beyondspring Inc ::BEYONDSPRING INITIATES GLOBAL PHASE 2/3 TRIAL WITH PLINABULIN IN CHINA FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NEUTROPENIA TO DEMONSTRATE SUPERIORITY.BEYONDSPRING INC - ‍EXPECT CFDA FILINGS OF FIRST NDAS FOR BOTH CIN AND NSCLC INDICATIONS POTENTIALLY IN 2018​. 

Company Quote

16.05
0.0 +0.00%
18 Jul 2019